The "Buddy" started to take profits by closing part of the ETH long position during the rebound.

Build-A-Bear Workshop releases revised full-year performance outlook

Harvard Bioscience expects its fiscal year 2026 performance growth will be strongly supported by a stable NIH funding environment and reduced tariff disruptions.

According to sources, the transaction in which Germany's Volkswagen Group sells a 51% stake in its subsidiary Everllence to financial investors will be conditional upon Porsche Holding simultaneously acquiring approximately 10% of Everllence's shares.

Aveanna Healthcare Holdings Inc. announced that its planned acquisition will be primarily funded through the company's existing cash reserves and a short-term credit facility.